ArticleFrontiers in immunology2025
Integrating pathomics and deep learning for subtyping uveal melanoma: identifying high-risk immune infiltration profiles.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- A Multitask Deep Learning Approach for Tumor Segmentation and Morphological Quantification in Acral Melanoma Whole-Slide Images.Journal of imaging informatics in medicine · 2026Article
- Data-driven strategies for immunoradiotherapy in uveal melanoma: the role of artificial intelligence.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Uveal melanoma (UVM) is the most common primary intraocular malignancy in adults, characterized by high mortality despite its relatively low incidence. This study aimed to utilize unsupervised learning techniques to identify a high immune infiltration subtype of UVM and improve patient stratification based on mortality risk. Methods: A total of 70 hematoxylin and eosin (H&E) stained whole-slide images (WSIs) of UVM were collected from the Genomic Data Commons (GDC) data portal, along with genomic and clinical data. An additional validation cohort of 68 UVM patients from West China Hospital was included. Pathomic features were extracted using CellProfiler software, and deep learning models were constructed for classification and survival prediction. Unsupervised clustering was performed to identify critical regions for prognosis prediction and patient classification. The relationship between histopathological features and genomics was explored. Results: The study achieved accurate prediction and classification of UVM patients using deep learning models and machine learning techniques. A high immune infiltration subtype of UVM was identified, which showed prognostic relevance. Unsupervised clustering categorized UVM patients into three distinct subgroups. The developed deep learning model based on the Inception-V3 architecture demonstrated promising results in survival prediction. Conclusion: This study demonstrates the potential of unsupervised learning and deep learning techniques in identifying a high immune infiltration subtype of UVM and improving patient stratification based on mortality risk. This research contributes to the field of computational pathology and highlights the potential of utilizing histopathological images, genomic data, and deep learning models in enhancing the management of UVM patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.